JPS6135166B2 - - Google Patents

Info

Publication number
JPS6135166B2
JPS6135166B2 JP51017820A JP1782076A JPS6135166B2 JP S6135166 B2 JPS6135166 B2 JP S6135166B2 JP 51017820 A JP51017820 A JP 51017820A JP 1782076 A JP1782076 A JP 1782076A JP S6135166 B2 JPS6135166 B2 JP S6135166B2
Authority
JP
Japan
Prior art keywords
weight
composition
solvent
glycol
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP51017820A
Other languages
English (en)
Japanese (ja)
Other versions
JPS51110043A (enExample
Inventor
Jei Horusen Boido
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of JPS51110043A publication Critical patent/JPS51110043A/ja
Publication of JPS6135166B2 publication Critical patent/JPS6135166B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paper (AREA)
JP51017820A 1975-02-21 1976-02-20 Expired JPS6135166B2 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/551,811 US3934013A (en) 1975-02-21 1975-02-21 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
JPS51110043A JPS51110043A (enExample) 1976-09-29
JPS6135166B2 true JPS6135166B2 (enExample) 1986-08-12

Family

ID=24202770

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51017820A Expired JPS6135166B2 (enExample) 1975-02-21 1976-02-20

Country Status (18)

Country Link
US (1) US3934013A (enExample)
JP (1) JPS6135166B2 (enExample)
AU (1) AU504748B2 (enExample)
BE (1) BE838711A (enExample)
BR (1) BR7600834A (enExample)
CA (1) CA1067409A (enExample)
DE (1) DE2605242A1 (enExample)
DK (1) DK68876A (enExample)
ES (1) ES445151A1 (enExample)
FI (1) FI67415C (enExample)
FR (1) FR2301262A1 (enExample)
GB (1) GB1502544A (enExample)
IE (1) IE43655B1 (enExample)
IL (1) IL48797A (enExample)
IT (1) IT1066085B (enExample)
NL (1) NL7601667A (enExample)
NZ (1) NZ180042A (enExample)
ZA (1) ZA7671B (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3864E (es) 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
ZA777493B (en) * 1976-12-17 1978-10-25 Scherico Ltd Improvements in or relating to antibiotic formulations
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
US4304765A (en) * 1980-10-14 1981-12-08 Alza Corporation Ocular insert housing steroid in two different therapeutic forms
US4432964A (en) * 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
US4482539A (en) * 1983-05-13 1984-11-13 Schering Corporation Betamethasone dipropionate cream
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
EP0196121A1 (en) * 1985-02-22 1986-10-01 Pera Dr. Visnjic Process for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
YU46838B (sh) * 1986-02-14 1994-06-24 Pero Dr. Višnjić Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa
US5002936A (en) * 1985-04-12 1991-03-26 Seymour Lieberman Lipophilic complexes of pharmacologically active inorganic mineral acid esters of organic compounds
US4780455A (en) * 1985-04-12 1988-10-25 The Trustees Of Columbia University In The City Of New York Lipophilic complexes of pharmacologically active organic compounds
US4792556A (en) 1985-09-09 1988-12-20 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
DE3534743A1 (de) * 1985-09-28 1987-04-02 Beiersdorf Ag Hydrocortisondiester enthaltende o/w-creme
US4740372A (en) * 1986-09-17 1988-04-26 Ljubomir Boncic Composition for treating psoriasis vulgaris and a method for its preparation
US5171737A (en) * 1989-03-03 1992-12-15 The Liposome Company, Inc. Emulsions
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
DE4234225A1 (de) * 1992-10-10 1994-04-14 Roehm Pharma Gmbh Stabile topische Formulierungen mit gutem Wirkstoff-Freisetzungsvermögen enthaltend mindestens ein lipophilisiertes Makrolidantibiotikum
UA39896C2 (uk) * 1993-10-22 2001-07-16 Смітклайн Бічам Корпорейшн Фармацевтична або ветеринарна композиція мупіроцину та спосіб її приготування
WO1996002254A1 (en) * 1994-07-15 1996-02-01 Michel Cohen SYNERGISTIC PHARMACEUTICAL COMPOSITONS CONTAINING 16'alpha',17'alpha'-ISOPROPYLIDENEDIOXY SUBSTITUTED PREGNANES
US5707981A (en) * 1994-07-28 1998-01-13 Psorial, L.L.C. Synergistic pharmaceutical compositions
RU2106860C1 (ru) * 1996-01-30 1998-03-20 Акционерное общество открытого типа "Нижегородский химико-фармацевтический завод" Состав и способ получения мази противовоспалительного и противозудного действия
US7179475B1 (en) 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
DE60015508T2 (de) 1999-03-05 2005-04-21 Univ Durham C-16 ungesätigte fp-selektive prostaglandin analoge
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US6765001B2 (en) * 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
WO2010013240A1 (en) 2008-07-31 2010-02-04 Dekel Pharmaceuticals Ltd. Compositions and methods for treating inflammatory disorders
US8722739B2 (en) * 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
ES2637447T3 (es) 2009-08-31 2017-10-13 Dr. Reddy's Laboratories Ltd. Formulaciones tópicas que contienen un esteroide
DK2366408T3 (da) * 2010-03-01 2012-10-22 Salvat Lab Sa Vandige, klare opløsninger af fluocinolonacetonid til behandling af inflammation i øret
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
CA2945943C (en) 2014-03-11 2020-10-27 Promius Pharma, LLC Topical corticosteroid compositions
PL409156A1 (pl) 2014-08-11 2016-02-15 Matonis Grzegorz Kompozycja kosmetyczna i/lub farmaceutyczna łagodząca objawy łuszczycy
US20200230082A1 (en) * 2017-07-11 2020-07-23 University Of Miami Topical acetaminophen formulations for itch relief
KR102891680B1 (ko) 2020-07-28 2025-11-27 아큐티스 바이오테라퓨틱스, 인크. Jak 저해제 및 라우레스-4를 함유하는 국소 제형
MX2024007437A (es) 2021-12-15 2024-09-04 Arcutis Biotherapeutics Inc Formulaciones estables de shr0302.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3073743A (en) * 1959-07-30 1963-01-15 Upjohn Co Antiinflammatory steroid acetonide compositions and therapy
US3472931A (en) * 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides

Also Published As

Publication number Publication date
FI67415C (fi) 1985-03-11
IE43655B1 (en) 1981-04-22
NZ180042A (en) 1978-07-28
US3934013A (en) 1976-01-20
FR2301262A1 (fr) 1976-09-17
ZA7671B (en) 1977-08-31
NL7601667A (nl) 1976-08-24
FI760344A7 (enExample) 1976-08-22
JPS51110043A (enExample) 1976-09-29
AU504748B2 (en) 1979-10-25
BR7600834A (pt) 1976-09-14
FR2301262B1 (enExample) 1979-04-06
IL48797A0 (en) 1976-03-31
BE838711A (fr) 1976-08-19
DK68876A (da) 1976-08-22
AU1085876A (en) 1977-03-17
FI67415B (fi) 1984-11-30
AU1068276A (en) 1977-08-04
IT1066085B (it) 1985-03-04
GB1502544A (en) 1978-03-01
IE43655L (en) 1976-08-21
IL48797A (en) 1979-01-31
ES445151A1 (es) 1977-05-16
DE2605242A1 (de) 1976-09-02
CA1067409A (en) 1979-12-04

Similar Documents

Publication Publication Date Title
JPS6135166B2 (enExample)
JP7402301B2 (ja) 水混和性の薬学的に許容可能な溶媒の水性ブレンド中のロフルミラストの医薬組成物
AU778889B2 (en) Novel topical oestroprogestational compositions with systemic effect
DE69715049T2 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
DE69430917T2 (de) 3-l-MENTHOXY-PROPANE-1, 2-DIOL ALS LÖSUNGSVERMITTLER UND EXTERNE ZUBEREITUNG, DIE DIESEN ENTHÄLT
DE69935135T2 (de) Topische hormonhaltige zusammensetzung mit systemischer wirkung
DE60315939T2 (de) Pharmazeutische zusammensetzung enthaltend ein androgen
CA2888853C (en) Topical steroid composition and method
US4070462A (en) Steroid ointment
WO1991008733A1 (en) Stable cream and lotion bases for lipophilic drug compositions
WO2000053186A1 (en) Topical compositions containing a combination of an antifungal agent and a steroidal antiinflammatory agent
US4831023A (en) Water washable vehicles for topical use
JPH0892097A (ja) ビフォナゾール含有殺真菌組成物
JP3487633B2 (ja) 皮膚疾患治療乳剤
JPH0643317B2 (ja) 抗炎症クリーム組成物
US5236906A (en) Topical therapeutic preparation
JPH02501739A (ja) ステロイドローション剤
JPH0244815B2 (enExample)
CA2616449C (en) Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases
JPH0676328B2 (ja) ステロイドクリ−ム製剤
EP1194109B1 (en) Topical formulations comprising skin penetration agents and the use thereof
JPS6218526B2 (enExample)
JPH0481569B2 (enExample)
CN115624520B (zh) 一种地奥司明乳膏剂和应用
WO2007086582A1 (ja) ２２－オキサ－１α,２５－ジヒドロキシビタミンＤ3を含有する水中油型乳剤性ローション剤およびそれを用いた皮膚疾患の治療方法